Knight Therapeutics Inc (OP: KHTRF )

4.320 +0.060 (+1.41%)

Streaming Delayed Price Updated: 11:55 AM EDT, May 7, 2024 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	16,000
Open	4.330
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	4.260
Today's Range	4.320 - 4.350
52wk Range	3.201 - 4.290
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Is Ardelyx is A Buy After Slip in Early 2022

November 21, 2022

Ardelyx is relatively new to the market and was doing well until a small drug approval issue last year. Strong earnings and smart partnerships could save them

Via MarketBeat

Knight Therapeutics Secures Rights To Rigel's Fostamatinib In Latin America

May 24, 2022

Knight Therapeutics Inc. (TSX: GUD) (OTC: KHTRF)

Via Benzinga

Performance

YTD	+11.45%	+11.45%
1 Month	+3.10%	+3.10%
3 Month	+9.09%	+9.09%
6 Month	+23.92%	+23.92%
1 Year	+19.53%	+19.53%

More News

Puma Biotech's Nerlynx Wins Canadian Approval In HER2-Positive Metastatic Breast Cancer

July 06, 2021

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.